Vascular endothelial cell growth factor-induced tissue factor expression in endothelial cells is mediated by EGR-1

Blood

Volumn 93, Issue 11, 1999, Pages 3811-3823

  Mechtcheriakova, Diana ^a   Wlachos, Alexander ^a   Holzmüller, Harry ^a   Binder, Bernd R ^a   Hofer, Erhard ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; THROMBOPLASTIN;

ANGIOGENESIS; ARTICLE; HEMOSTASIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR AFFINITY; THROMBOSIS; TRANSCRIPTION REGULATION; VASCULAR ENDOTHELIUM;

EID: 0033152286     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.11.3811.411k40_3811_3823     Document Type: Article

References (59)

1. Edgington TS, Ruf W, Rehemtulla A, Mackman N: The molecular biology of initiation of coagulation by tissue factor. Curr Stud Hematol Blood Transfus 58:15, 1991
2. Martin DM, Boys CW, Ruf W: Tissue factor: Molecular recognition and cofactor function. FASEB J 9:852, 1995
3. Mackman N: Regulation of the tissue factor gene. FASEB J 9:883, 1995
4. Moll T, Czyz M, Holzmuller H, Hofer Warbinek R, Wagner E, Winkler H, Bach FH, Hofer E: Regulation of the tissue factor promoter in endothelial cells. Binding of NF kappa B-, AP-1-, and Sp1-like transcription factors. J Biol Chem 270:3849, 1995
5. Zhang Y, Deng Y, Luther T, Muller M, Ziegler R, Waldherr R, Stern DM, Nawroth PP: Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest 94:1320, 1994
6. Contrino J, Hair G, Kreutzer DL, Rickles FR: In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease. Nat Med 2:209, 1996
7. Shoji M, Hancock WW, Abe K, Micko C, Casper KA, Baine RM, Wilcox JN, Danave I, Dillehay DL, Matthews E, Contrino J, Morrissey JH, Gordon S, Edgington TS, Kudryk B, Kreutzer DL, Rickles FR: Activation of coagulation and angiogenesis in cancer: Immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am J Pathol 152:399, 1998
8. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC, Pan YC, Olander JV, Connolly DT, Stern D: Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 172:1535, 1990
9. Breier G, Risau W: The role of vascular endothelial growth factor in blood vessel formation. Trends Cell Biol 6:454, 1996
10. Bussolino F, Mantovani A, Persico G: Molecular mechanisms of blood vessel formation. Trends Biochem Sci 22:251, 1997
11. D'Angelo G, Struman I, Martial J, Weiner RI: Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin. Proc Natl Acad Sci USA 92:6374, 1995
12. Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S, Shibuya M: A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene 10:135, 1995
13. Waltenberger J, Claesson Welsh L, Siegbahn A, Shibuya M, Heldin CH: Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 269:26988, 1994
14. Baeuerle PA, Baichwal VR: NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv Immunol 65:111, 1997
15. Cui MZ, Parry GC, Oeth P, Larson H, Smith M, Huang RP, Adamson ED, Mackman N: Transcriptional regulation of the tissue factor gene in human epithelial cells is mediated by Sp1 and EGR-1. J Biol Chem 271:2731, 1996
16. Yan SF, Zou YS, Gao Y, Zhai C, Mackman N, Lee SL, Milbrandt J, Pinsky D, Kisiel W, Stern D: Tissue factor transcription driven by Egr-1 is a critical mechanism of murine pulmonary fibrin deposition in hypoxia. Proc Natl Acad Sci USA 95:8298, 1998
17. Christy BA, Lau LF, Nathans D: A gene activated in mouse 3T3 cells by serum growth factors encodes a protein with "zinc finger" sequences. Proc Natl Acad Sci USA 85:7857, 1988
18. Lemaire P, Revelant O, Bravo R, Charnay P: Two mouse genes encoding potential transcription factors with identical DNA-binding domains are activated by growth factors in cultured cells. Proc Natl Acad Sci USA 85:4691, 1988
19. Milbrandt J: A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. Science 238:797, 1987
20. Sukhatme VP, Cao XM, Chang LC, Tsai Morris CH, Stamenkovich D, Ferreira PC, Cohen DR, Edwards SA, Shows TB, Curran T, LeBeau M, Adamson E: A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell 53:37, 1988
21. Cao X, Koski RA, Gashler A, McKiernan M, Morris CF, Gaffney R, Hay RV, Sukhatme VP: Identification and characterization of the Egr-1 gene product, a DNA-binding zinc finger protein induced by differentiation and growth signals. Mol Cell Biol 10:1931, 1990
22. Dey BR, Sukhatme VP, Roberts AB, Sporn MB, Rauscher F Jr, Kim SJ: Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product. Mol Endocrinol 8:595, 1994
23. Verde P, Boast S, Franze A, Robbiati F, Blasi F: An upstream enhancer and a negative element in the 5′ flanking region of the human urokinase plasminogen activator gene. Nucleic Acids Res 16:10699, 1988
24. Khachigian LM, Collins T: Inducible expression of Egr-1-dependent genes: A paradigm of transcriptional activation in vascular endothelium. Circ Res 81:457, 1997
25. Cao X, Mahendran R, Guy GR, Tan YH: Detection and characterization of cellular EGR-1 binding to its recognition site. J Biol Chem 268:16949, 1993
26. Wojta J, Hoover RL, Daniel TO: Vascular origin determines plasminogen activator expression in human endothelial cells. J Biol Chem 264:2846, 1989
27. Zhang J-C, Fabry A, Paucz L, Wojta J, Binder BR: Human fibroblasts downregulate plasminogen activator inhibitor type-1 in cultured human macrovascular and microvascular endothelial cells. Blood 88:3880, 1996
28. Blume SW, Snyder RC, Ray R, Thomas S, Koller CA, Miller DM: Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J Clin Invest 88:1613, 1991
29. Snyder RC, Ray R, Blume S, Miller DM: Mithramycin blocks transcriptional initiation of the c-myc P1 and P2 promoters. Biochemistry 30:4290, 1991
30. Ryuto M, Ono M, Izumi H, Yoshida S, Weich HA, Kohno K, Kuwano M: Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1. J Biol Chem 271:28220, 1996
31. Dignam JD, Lebovitz RM, Roeder RG: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475, 1983
32. de Martin R, Strasswimmer J, Philipson L: A new luciferase promoter insertion vector for the analysis of weak transcriptional activities. Gene 124:137, 1993
33. Gashler AL, Swaminathan S, Sukhatme VP: A novel repression module, an extensive activation domain, and a bipartite nuclear localization signal defined in the immediate-early transcription factor Egr-1. Mol Cell Biol 13:4556, 1993
34. de Wet JR, Wood KV, DeLuca M, Helinski DR, Subramani S: Firefly luciferase gene: Structure and expression in mammalian cells. Mol Cell Biol 7:725, 1987
35. Jain VK, Magrath IT: A chemiluminescent assay for quantitation of beta-galactosidase in the femtogram range: Application to quantitation of beta-galactosidase in lacZ-transfected cells. Anal Biochem 199:119, 1991
36. Wolff B, Cohen G, Hauber J, Mechtcheriakova D, Rabeck C: Nucleocytoplasmic transport of the Rev protein of human immunodeficiency virus type 1 is dependent on the activation domain of the protein. Exp Cell Res 217:31, 1995
37. Gitay Goren H, Cohen T, Tessler S, Soker S, Gengrinovitch S, Rockwell P, Klagsbrun M, Levi BZ, Neufeld G: Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells. J Biol Chem 271:5519, 1996
38. Clauss M, Weich H, Breier G, Knies U, Rockl W, Waltenberger J, Risau W: The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem 271:17629, 1996
39. Mackman N, Brand K, Edgington TS: Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites. J Exp Med 174:1517, 1991
40. Gille J, Swerlick RA, Caughman SW: Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation. EMBOJ 16:750, 1997
41. Camerer E, Rottingen JA, Iversen JG, Prydz H: Coagulation factors VII and X induce Ca(2+) oscillations in Madin-Darby canine kidney cells only when proteolytically active. J Biol Chem 271:29034, 1996
42. Carmeliet P, Mackman N, Moons L, Luther T, Gressens P, Van Vlaenderen I, Demunck H, Kasper M, Breier G, Evrard P, Muller M, Risau W, Edgington T, Collen D: Role of tissue factor in embryonic blood vessel development. Nature 383:73, 1996
43. Bromberg ME, Konigsberg WH, Madison JF, Pawashe A, Garen A: Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc Natl Acad Sci USA 92:8205, 1995
44. Mueller BM, Ruf W: Requirement for binding of catalytically active factor VIIa in tissue factor dependent experimental metastasis. J Clin Invest 101:1372, 1998
45. Folkman J, D'Amore PA: Blood vessel formation: What is its molecular basis? Cell 87:1153, 1996
46. Arenander AT, Lim RW, Varnum BC, Cole R, De Vellis J, Herschman HR: TIS gene expression in cultured rat astocytes: Induction by mitogens and stellation agents. J Neurosci Res 23:247, 1989
47. Wang Z, Lin XH, Qiu QQ, Deuel TF: Modulation of transcription of the platelet-derived growth factor A-chain gene by a promoter region sensitive to S1 nuclease. J Biol Chem 267:17022, 1992
48. Waters C, Hancock D, Evan G: Identification and characterisation of the egr-1 gene product as an inducible, short-lived, nuclear phosphoprotein. Oncogene 5:669, 1990
49. Nigg E, Hilz H, Eppenberger H, Dutly F: Rapid and reversible translocation of the catalytic subunit of cAMP-dependent protein kinase type II from the Golgi complex to the nucleus. EMBO J 4:2801, 1985
50. Guiochon Mantel A, Loosfelt H, Lescop P, Sar S, Atger M, Perrot Applanat M, Milgrom E: Mechanisms of nuclear localization of the progesterone receptor: Evidence for interaction between monomers. Cell 57:1147, 1989
51. Baeuerle PA, Henkel T: Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12:141, 1994
52. Sekimoto T, Imamoto N, Nakajima K, Hirano T, Yoneda Y: Extracellular signal-dependent nuclear import of Stat1 is mediated by nuclear pore-targeting complex formation with NPI-1, but not Rch1. EMBO J 16:7067, 1997
53. Metz R, Ziff E: cAMP stimulates the C/EBP-related transcription factor rNFIL-6 to trans-locate to the nucleus and induce c-fos transcription. Genes Dev 5:1754, 1991
54. Roux P, Blanchard JM, Fernandez A, Lamb N, Jeanteur P, Piechaczyk M: Nuclear localization of c-Fos, but not v-Fos proteins, is controlled by extracellular signals. Cell 63:341, 1990
55. Verona R, Moberg K, Estes S, Starz M, Vernon JP, Lees JA: E2F activity is regulated by cell cycle-dependent changes in subcellular localization. Mol Cell Biol 17:7268, 1997
56. Ott I, Fischer E, Miyagi Y, Mueller B, Ruf W: A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280. J Cell Biol 140:1241, 1998
57. Cottam DW, Corbitt RH, Gomez DE, Rees RC, Thorgeirsson UP: Alterations in endothelial cell proteinase and inhibitor polarized secretion following treatment with interleukin-1, phorbol ester, and human melanoma cell conditioned medium. J Cell Biochem 60:148, 1996
58. Narahara N, Enden T, Wiiger M, Prydz H: Polar expression of tissue factor in human umbilical vein endothelial cells. Arterioscler Thromb 14:1815, 1994
59. Mackman N, Morrissey JH, Fowler B, Edgington TS: Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade. Biochemistry 28:1755, 1989